For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zoetis Inc (NYSE: ZTS) closed the day trading at $175.20 up 0.22% from the previous closing price of $174.81. In other words, the price has increased by $0.22 from its previous closing price. On the day, 1.25 million shares were traded. ZTS stock price reached its highest trading level at $177.67 during the session, while it also had its lowest trading level at $175.255.
Ratios:
For a better understanding of ZTS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 40.48 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 45.68. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 3.33. In the meantime, Its Debt-to-Equity ratio is 1.34 whereas as Long-Term Debt/Eq ratio is at 1.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 12, 2024, Reiterated its Buy rating but revised its target price to $215 from $195 previously.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $237.Exane BNP Paribas initiated its Outperform rating on December 07, 2023, with a $237 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 18 ’24 when Lagano Roxanne sold 923 shares for $151.17 per share. The transaction valued at 139,530 led to the insider holds 14,800 shares of the business.
Lagano Roxanne sold 923 shares of ZTS for $159,984 on Mar 18 ’24. The Executive Vice President now owns 15,723 shares after completing the transaction at $173.33 per share. On Mar 11 ’24, another insider, Reed Willie M, who serves as the Director of the company, sold 1,370 shares for $182.68 each. As a result, the insider received 250,265 and left with 9,994 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 80125403136 and an Enterprise Value of 84944429056. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.77, and their Forward P/E ratio for the next fiscal year is 27.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.15 while its Price-to-Book (P/B) ratio in mrq is 15.83. Its current Enterprise Value per Revenue stands at 9.726 whereas that against EBITDA is 23.814.
Stock Price History:
The Beta on a monthly basis for ZTS is 0.86, which has changed by 0.04232204 over the last 52 weeks, in comparison to a change of 0.25510752 over the same period for the S&P500. Over the past 52 weeks, ZTS has reached a high of $201.92, while it has fallen to a 52-week low of $144.80. The 50-Day Moving Average of the stock is 3.77%, while the 200-Day Moving Average is calculated to be -0.91%.
Shares Statistics:
Over the past 3-months, ZTS traded about 3.19M shares per day on average, while over the past 10 days, ZTS traded about 2801660 shares per day. A total of 458.37M shares are outstanding, with a floating share count of 455.93M. Insiders hold about 0.08% of the company’s shares, while institutions hold 95.62% stake in the company. Shares short for ZTS as of 1718323200 were 6876737 with a Short Ratio of 2.16, compared to 1715731200 on 6032053. Therefore, it implies a Short% of Shares Outstanding of 6876737 and a Short% of Float of 1.50999995.
Dividends & Splits
ZTS’s forward annual dividend rate is 1.61, up from 1.557 a year ago. Against a Trailing Annual Dividend Yield of 0.008906813The stock’s 5-year Average Dividend Yield is 0.65.
Earnings Estimates
The market rating for Zoetis Inc (ZTS) is a result of the insights provided by 10.0 analysts actively involved in the assessment.On average, analysts expect EPS of $1.5 for the current quarter, with a high estimate of $1.56 and a low estimate of $1.46, while EPS last year was $1.41. The consensus estimate for the next quarter is $1.47, with high estimates of $1.51 and low estimates of $1.43.
Analysts are recommending an EPS of between $5.8 and $5.73 for the fiscal current year, implying an average EPS of $5.77. EPS for the following year is $6.38, with 15.0 analysts recommending between $6.89 and $6.13.
Revenue Estimates
9 analysts predict $2.31B in revenue for the current quarter. It ranges from a high estimate of $2.33B to a low estimate of $2.29B. As of the current estimate, Zoetis Inc’s year-ago sales were $2.17BFor the next quarter, 9 analysts are estimating revenue of $2.3B. There is a high estimate of $2.32B for the next quarter, whereas the lowest estimate is $2.28B.
A total of 15 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.2B, while the lowest revenue estimate was $9.12B, resulting in an average revenue estimate of $9.15B. In the same quarter a year ago, actual revenue was $8.54BBased on 15 analysts’ estimates, the company’s revenue will be $9.72B in the next fiscal year. The high estimate is $10B and the low estimate is $9.18B.
